Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charan Behl currently holds 600,000 shares of ELITE PHARMACEUTICALS INC /DE/ (ELI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charan Behl has been a net buyer of ELI stock. They have purchased $116.8K and sold $0 worth of shares.
Charan Behl's most recent insider trade was on Sep 19, 2008, when they purchased 10,000 shares at $0.09 per share.
Charan Behl serves as Executive at ELITE PHARMACEUTICALS INC /DE/ (ELI). They have executed 27 insider transactions totaling $116.8K over their tenure at the company.
Charan Behl holds the position of Executive at ELITE PHARMACEUTICALS INC /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Charan Behl has shown a buying trading pattern, with $116.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Charan Behl was on Apr 2, 2008, when they purchased $12.0K worth of ELI shares. This transaction involved 15,000 shares at $0.80 per share.
Charan Behl currently owns 600,000 shares of ELITE PHARMACEUTICALS INC /DE/ (ELI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charan Behl's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charan Behl has 27 Form 4 filings on record as an insider at ELITE PHARMACEUTICALS INC /DE/.
Set alerts for Charan Behl and 40,000+ other insiders.